# Add-on implantation of the smaller-incision new generation implantable miniature telescope (SING IMT™) in pseudophakic eyes

**Authors:** Marco Pellegrini, Ginevra Giovanna Adamo, Antonio Cartabellotta, Pietro Maria Talli, Sabrina Crisafulli, Francesco Parmeggiani, Marco Mura

PMC · DOI: 10.1186/s40942-025-00797-9 · International Journal of Retina and Vitreous · 2026-01-23

## TL;DR

A new surgical method implants a miniature telescope in pseudophakic eyes to improve vision in advanced macular degeneration patients.

## Contribution

A novel add-on sulcus implantation technique for SING IMT™ in pseudophakic eyes is introduced and shown to be feasible.

## Key findings

- Surgical implantation was uneventful with stable device positioning and no major complications.
- Visual acuity improved by 3–4 ETDRS lines with enhanced daily visual function reported.
- Corneal endothelial loss remained under 5% at six months post-surgery.

## Abstract

To describe a novel surgical technique for add-on sulcus implantation of the Smaller-Incision New Generation Implantable Miniature Telescope (SING IMT™) in pseudophakic eyes with end-stage age-related macular degeneration (AMD).

Two pseudophakic patients with bilateral end-stage AMD underwent add-on SING IMT™ implantation in the ciliary sulcus. Pre- and postoperative evaluations included best-corrected distance visual acuity (BCDVA), anterior segment OCT (AS-OCT), corneal endothelial cell counts, and subjective visual function assessments, with follow-up to 6 months.

Both surgeries were uneventful. The devices remained stable and well-centered with no significant inflammation, corneal decompensation, or intraocular pressure elevation. BCDVA improved by 3–4 ETDRS lines, and both patients reported improved daily visual function. Corneal endothelial loss was < 5% at 6 months.

Add-on sulcus implantation of the SING IMT™ in pseudophakic eyes is surgically feasible and well tolerated, expanding the potential indications of this visual rehabilitation device to a broader AMD population.

The online version contains supplementary material available at 10.1186/s40942-025-00797-9.

## Linked entities

- **Diseases:** age-related macular degeneration (MONDO:0005150), AMD (MONDO:0005150)

## Full-text entities

- **Diseases:** atrophy (MESH:D001284), retinal edema (MESH:D010211), vision loss (MESH:D014786), AMD (MESH:D008268), astigmatism (MESH:D001251), cataract (MESH:D002386), corneal edema (MESH:D015715), SING IMT (MESH:D057873), inflammation (MESH:D007249), trauma (MESH:D014947), glaucoma (MESH:D005901), retinal (MESH:D012173), end (MESH:D003643)
- **Chemicals:** AS-OCT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12874954/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12874954/full.md

---
Source: https://tomesphere.com/paper/PMC12874954